Invest ¥121 million! BSM(Tongling) plans to build 12,100 tons of Cyclopentane series green new material project
Recently, Tongling BSM’s annual output of 12,100 tons of Cyclopentane series green new material project was publicized on the relevant website.
Project location: Tongling Economic Development Zone, Tongling City, Anhui Province, new chemical materials concentration area
The estimated total investment of the project: 121.03 million yuan
Project construction content and scale: Relying on the existing Pentanone series of green new material projects in the plant, the new Cyclopentane/Cyclopentene device and hydrogen production device, and the purchase of dimerization reactor, full hydrogenation reactor, deweighting tower, deweighting tower, rectification tower and other equipment, after the completion of the project, the annual production scale of 8,000 tons of Cyclopentene and 4,100 tons of Cyclopentane will be formed.
BSM(Tongling), a wholly-owned subsidiary of Shaoxing BSM, was established on October 26, 2020, and is registered at Linjin Avenue, East Park, Tongling Economic Development Zone, Anhui Province. Shaoxing BSM was established on March 31, 2003, and is registered in Shangyu Economic and Technological Development Zone, Shangyu Bay, Shangyu District, Shaoxing City, Zhejiang Province.
2026-10-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BSM: Generic has obtained multiple pesticide registrations in Brazil and has begun to contribute revenue and profit
-
BSM: Pendimethalin will reach 18,000 t/a after expansion, combining the advantages of Generic to explore the Asian, African and Latin American markets
-
BSM intends to acquire 80% of Generic for ¥348 million, and will be wholly owned after the transaction
-
Some of BSM's fundraising projects have been delayed; Stable performance and positive net profit growth in the first half of the year
-
BSM is expected to make anet profit of 44 million to 52 million yuan, with full orders of Pendimethalin in the first quarter of 2023,
-
BSM's Pendimethalin is expected to increase in overseas markets
-
China丨BSM Chemical H1 report: operating revenue up 34.9% yoy
-
Syngenta Caught in Trade Crossfire
-
5%–10% Is Just the Surface: Behind Dow’s Greater China Price Letter Lies a Global Repricing of Silicones
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
Recommend Reading
-
BASF Brings Biomass-Balance Polyols to North America
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
April Chemical Industry Shutdown Wave Arrives: Maintenance Plans Reflect Deep Cost Anxiety Across Enterprises
-
Cost-driven fluctuations and decline in phthalic anhydride market prices in 2025; prices may first strengthen and then stabilize in 2026
-
India Prepares New Seed and Pesticide Laws
-
EFSA Reviews Clodinafop Risk
-
Supportive Factors Drive Recent Polyethylene Price Increases in China
-
Supply and Demand Boost Formic Acid Prices Gradually in China